00401 WANJIA GROUP
- 0.085
- +0.015+21.43%
WANJIA GROUP News
Wanjia Group (00401): He Min Resigns as Independent Non-Executive Director
Wanjia Group (00401) issued an announcement, effective April 30, 2024: He Min has submitted a statement to the board of directors...
CITIC Construction Investment Securities: Optimistic about investment opportunities in the medical device sector, focusing on the three main lines driven by policy inflection points, internationalization, and innovation
CITIC Construction Investment Securities released a research report saying that looking ahead to 2024, it will continue to be optimistic about investment opportunities in the medical device sector, and is optimistic about the three main lines of policy inflection points, internationalization, and innovation.
WANJIA GROUP: Interim Report 2023/2024
Wanjia Group Holdings Incurs Wider Loss in Fiscal H1
Wanjia Group Holdings (HKG:0401) incurred a wider loss of HK$3.1 million, or HK$0.0054 per share, in the fiscal first half, from HK$2.5 million, or HK$0.0045 per share, in the year-ago period, a Monda
Wanjia Group (00401) announced interim results, losses attributable to shareholders of HK$3.05 million increased by 21.71% year-on-year
Wanjia Group (00401) announced interim results for the six months ended September 30, 2023. The group obtained during the period...
WANJIA GROUP: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Wanjia Group (00401.HK) granted a total of 56 million share options
GLONGHUI, September 5, 丨 Wanjia Group (00401.HK) announced that the board of directors has resolved to grant a total of 56 million share options to the grantor on September 5, 2023. The exercise price of the share options has been granted at HK$0.094 per share, and the closing price of the company on the grant date is HK$0.092 per share.
WANJIA GROUP: Annual Report 2022/23
Wanjia Group Swings to Profit in FY23 on Higher Revenue
Wanjia Group Holdings (HKG:0401) swung to an attributable profit of HK$1.8 million, or HK$0.0032 per share, in the fiscal year ended March 31, from a loss of HK$51 million, or HK$0.0910 per share, a y
Featured Announcements | Taobo: The total sales volume of the retail and wholesale business in the past fiscal quarter recorded a low 20-30% year-on-year increase
Shiyao Group: The first domestic anti-GFRAL monoclonal antibody JMT203 was approved for clinical trials in China; L'Occitane: Group sales reached 2,135 billion euros in FY2023.
Wanjia Group (00401.HK) turned an annual loss into a profit of HK$1.82 million
GLONGHUI, June 26丨Wanjia Group (00401.HK) announced that for the year ending March 31, 2023, total revenue was about HK$174 million, up about 12.19% from 2022; gross profit was about HK$56.936 million, up about 4.98% from 2022; operating business profit was about HK$4.473 million, operating loss of about HK$47.383 million in 2022; company owners should account for an annual profit of about HK$1.82 million; in 2022, company owners should account for an annual loss of about HK$50,999 million). Basic and diluted earnings per share were approximately 0.
Wanjia Group (00401) announced its annual results. Shareholders' profit accounts for about HK$1.82 million, turning a year-on-year loss into a profit
According to the Zhitong Finance App, Wanjia Group (00401) announced the results for the year ended March 31, 2023, with total revenue of about HK$174 million, an increase of about 12.19% over the previous year; profit attributable to company owners was about HK$1.82 million (2022: company owners should account for this year's losses of about HK$50,999 million); basic and diluted profit per share is about HK$0.32 cents. According to reports, the Group's loss turned profit this year due to continued improvements in the Group's operations in the Hemodialysis Treatment and Counseling Services business category in China.
WANJIA GROUP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2023
Wanjia Group Holdings Sees Return to Profit in FY23
Wanjia Group Holdings (HKG:0401) sees a return to an attributable profit of not more than HK$2 million in the fiscal year ended March 31 from a loss of HK$51 million a year earlier, a Friday filing sa
WANJIA GROUP: POSITIVE PROFIT ALERT
Wanjia Group (00401.HK) held a board meeting on June 26 to consider and approve annual results
Glonghui, June 9 丨 Wanjia Group (00401.HK) announced that the Board of Directors will meet at 3:00 p.m. on June 26, 2023 (Monday) at 3:00 p.m., to discuss the following matters: 1. Consider and adopt the audited annual results of the Company and its subsidiaries for the year ended March 31, 2023 (“Annual Results”) and the publication of the relevant annual results announcements on the Hong Kong Stock Exchange Limited's website and the company's website; 2. Consider payment of final dividends (if any); 3. Consider suspending the processing of company shares
WANJIA GROUP: NOTICE OF BOARD MEETING
Wanjia Group (00401) plans to sell all shares of Huidong Yanghe Renal Hemodialysis Co., Ltd. for 3.5 million yuan
According to the Zhitong Finance App, Wanjia Group (00401) issued an announcement. On March 31, 2023, the seller (Zhuhai Shengchuang Medical Investment Management Co., Ltd., wholly-owned subsidiary of the company) entered into a sale agreement with the buyer (Zhuhai Junyi Technology Co., Ltd.). The seller conditionally agreed to sell the sales rights (all of the target company's shares). The cost was RMB 3.5 million. According to reports, the target company is Huidong Yanghe Nephrology Hemodialysis Co., Ltd., which was established in Huidong, Guangdong, China on October 10, 2016. The target company has the right to carry out hemodialysis business and its operation in accordance with relevant laws and regulations. Huidong Center is a set of goals
Wanjia Group: interim report 2022 Universe 2023
Wanjia Group Swings to $320,600 For Six-Month Period
06:48 AM EST, 11/23/2022 (MT Newswires) -- Wanjia Group Holdings (HKG:0401) swung to a loss attributable to the company's owners of HK$2.51 million ($320,600) for the six months ending Sept. 30 from t
Analysis
Price Target
No Data
